Targeting Mutant <i>KRAS</i> in Pancreatic Cancer: Futile or Promising?
Pancreatic ductal adenocarcinoma (PDAC) is one of the most fatal cancers with a dismal prognosis for the patient. This is due to limited diagnostic options for the early detection of the disease as well as its rather aggressive nature. Despite major advances in oncologic research in general, the tre...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
MDPI AG
2020-08-01
|
| Serie: | Biomedicines |
| Soggetti: | |
| Accesso online: | https://www.mdpi.com/2227-9059/8/8/281 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|